Context.-Pancreatic neuroendocrine tumors (PancNETs) are rare and tend to get overshadowed by their more prevalent and aggressive ductal adenocarcinoma counterparts. The biological behavior of PancNETs is unpredictable, and thus management is controversial. However, the new World Health Organization classification has significantly contributed to the prognostic stratification of these patients. Concurrently, there have been advances in surgical techniques for benign or lowgrade pancreatic tumors. These procedures include minimally invasive and parenchyma-sparing operations such as laparoscopy and enucleation.Objective.-To report on the utility and limitations of fine-needle aspiration in the preoperative evaluation and management of PancNETs.Design.-This was a retrospective review of our institutional tumor database from 2002 to 2012. There were 25 cases of PancNETs that were localized and staged by medical imaging and diagnosed by fine-needle aspiration.Results.-Fourteen patients underwent laparotomy, with some requiring only limited surgery; 4 had laparoscopic resections; 4 were serially observed without surgical intervention; and another 3 were inoperable. After a mean follow-up of 37 months, more than half of the patients had no evidence of disease, including most of those who underwent minimally invasive surgery.Conclusions.-Fine-needle aspiration is a useful diagnostic adjunct to medical imaging in the preoperative evaluation and management of PancNETs. However, there are limitations with regard to grading PancNETs using this technique.(Arch Pathol Lab Med. 2014;138:896-902; doi: 10.5858/ arpa.2013-0300-OA) C ross-sectional imaging, endoscopic ultrasound (EUS), and fine-needle aspiration (FNA) are important in the preoperative evaluation of pancreatic masses.1-4 Although the majority of pancreatic tumors are ductal adenocarcinomas, other neoplasms such as neuroendocrine tumors, acinar cell carcinomas, solid pseudopapillary neoplasms, cystic neoplasms, and metastases also occur. 5,6 Pancreatic neuroendocrine tumors (PancNETs) are a particularly interesting group of neoplasms because they can present clinically with neuroendocrine manifestations or remain silent until their presence is heralded by mass effect. They can be single and sporadic or can be a component of several syndromes.2-4 The biological behavior of PancNETs is unpredictable, especially in the absence of locoregional spread or metastases. Thus, the management is controversial. However, there is now a growing consensus that the new World Health Organization (WHO) classification has significantly contributed to the prognostic stratification of these patients.7-9 Concurrently, there have been advances in surgical techniques for benign or low-grade pancreatic tumors. These procedures include minimally invasive and parenchyma-sparing operations such as laparoscopy and enucleation.10-13 Herein, we report on the utility and limitations of FNA in the preoperative evaluation and management of PancNETs in light of these developments.
MATERIALS AND METHO...